ID 1101

Drug Profile

ID 1101

Alternative Names: Adyvia; ID1101

Latest Information Update: 10 Mar 2009

Price : $50

At a glance

  • Originator Innodia
  • Class Antihyperglycaemics; Branched-chain amino acids; Small molecules
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Obesity

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 17 Jul 2008 Innodia has been acquired by BELLUS Health
  • 05 Dec 2006 Phase-II clinical trials in Obesity in Canada (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top